Regeneron Pharmaceuticals Inc (REGN)

Return on equity (ROE)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands 3,953,600 3,991,100 4,299,000 4,182,700 4,338,400 5,370,300 5,686,800 7,933,600 8,075,300 6,995,500 6,205,400 4,003,800 3,513,200 3,156,000 2,983,500 2,279,300 2,115,800 2,144,200 2,069,300 2,427,600
Total stockholders’ equity US$ in thousands 25,973,100 24,904,400 24,017,900 23,495,200 22,664,000 21,438,800 20,687,800 19,914,700 18,768,800 17,258,000 15,127,300 11,977,000 11,025,300 10,125,500 9,057,400 12,133,000 11,089,700 10,504,400 9,755,900 9,444,700
ROE 15.22% 16.03% 17.90% 17.80% 19.14% 25.05% 27.49% 39.84% 43.03% 40.53% 41.02% 33.43% 31.86% 31.17% 32.94% 18.79% 19.08% 20.41% 21.21% 25.70%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $3,953,600K ÷ $25,973,100K
= 15.22%

Regeneron Pharmaceuticals, Inc.'s return on equity (ROE) showed a decreasing trend over the past eight quarters, with the ROE declining from 39.84% in Q1 2022 to 15.22% in Q4 2023. This suggests that the company's profitability in generating returns from shareholders' equity has been gradually decreasing over this period. The significant drop in ROE from Q2 2022 (27.49%) to Q3 2022 (25.05%) may warrant further investigation into the factors contributing to this decline.

A declining ROE could indicate decreasing efficiency in utilizing equity to generate profits or declining profitability relative to equity investments. Investors and analysts may want to assess the company's financial strategy, operational performance, and capital structure to understand the reasons behind this trend and evaluate the sustainability of Regeneron Pharmaceuticals, Inc.'s financial performance.


Peer comparison

Dec 31, 2023


See also:

Regeneron Pharmaceuticals Inc Return on Equity (ROE) (Quarterly Data)